Advertisement

Topics

NSW Health Funds Indee Labs’ First Preclinical Study Into Gene-Modified Cell Therapy Manufacturing for Blood Cancer

01:58 EDT 9 Aug 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
This preclinical study will pave the way for biopharmaceutical companies to transition away from using viruses. The aim is to enable gene-modified cell therapy manufacturing with open source biology to provide patients with impr...

Other Sources for this Article

Indee Labs Australia
Warren McKenzie, +61 400 059 509
Chief Executive Officer
warren@indeelabs.com
indeelabs.com

NEXT ARTICLE

More From BioPortfolio on "NSW Health Funds Indee Labs’ First Preclinical Study Into Gene-Modified Cell Therapy Manufacturing for Blood Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...